ROSA Robotic Surgery System to be Highlighted at Two Medical Congresses

MONTPELLIER, France, Oct. 12, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, has announced that its ROSA™ robot will be exhibited at two major medical congresses in October.

The annual North American Spine Society (NASS) congresswill be held from October 14 - 16 in Chicago, USA. This event gathers together the whole community of North American spine surgeons along with international attendees. Medtech will provide hands-on demonstrations of ROSA™ at its booth (#635) at NASS. The Company will also host a Round Table event featuring Dr. Michel LEFRANC, neurosurgeon at Amiens-Picardy University Hospital, who will share his experience and present his results using the ROSA™ robot for pedicle screw fixation procedures (5.30 p.m. CT on October 14).

Medtech will also be present at the European Society of Neurosurgery (EANS) congress in Madrid, Spain, from October 18 - 21 (Booth #2). The EANS congress is a major event in the field of neurosurgery, gathering together around 1,000 experts in surgery of the central nervous system (brain and spine).


Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.

In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.

In 2013 MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.

In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.

In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.

CONTACT: CONTACT MEDTECH Christophe Sibillin Chief Financial Officer Tel : +33 (0)4 67 10 77 40 INVESTORS Corinne Puissant Tel : +33 (0)1 53 67 36 77 PRESS Alexandra Prisa (EU) Tel : +33(0)1 53 67 36 90 Joanna Zimmerman (US) Tel : +1 646-536-7006

Source:Medtech SA